Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.3608
-0.0473 (-11.59%)
At close: Jun 6, 2025, 4:00 PM
0.3518
-0.0090 (-2.49%)
After-hours: Jun 6, 2025, 5:39 PM EDT
Cellectar Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
n/a
Upside
n/a
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 14, 2025 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +3,225.94% | Nov 19, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +3,780.27% | Oct 11, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +7,660.53% | Mar 28, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +3,225.94% | Mar 28, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +5,443.24% | Mar 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | +1,008.65% | Nov 4, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +15,143.90% | Jul 18, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +13,758.09% | Jul 1, 2020 |
Maxim Group | Maxim Group | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +8,214.86% | Jun 23, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +27,616.19% | Jan 21, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +30,387.80% | Sep 13, 2019 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +74,733.70% | Dec 21, 2016 |